Home › Plasma Cell Cancer › California
Plasma Cell Cancer clinical trials in California
3 studies for Plasma Cell Cancer are looking for participants at sites in California.
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
- Beverly Hills Cancer Center, Beverly Hills
- Clovis Community Medical Center, Clovis
- Community Cancer Institute, Clovis
- and 9 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT06152575A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
- UCSF Medical Center - Hematology and Blood and Marrow Transplant Clinic, San Francisco
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT05651932Delayed Toxicities Post-CAR-T
- UCSF Medical Center, San Francisco
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT07665307From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.